Switching from current factor VIII (FVIII) to longer acting FVIII concentrates - what is the real potential benefit?-Reference-Cited by-同舟云学术

Switching from current factor VIII (FVIII) to longer acting FVIII concentrates - what is the real potential benefit?

Published:2015-04-09 Issue:3 Volume:21 Page:297-299
ISSN:1351-8216
Container-title:Haemophilia
language:en
Short-container-title:Haemophilia

Author:

Carcao M.¹

Affiliation:

1. Division of Haematology/Oncology; Department of Paediatrics and Research Institute; Hospital for Sick Children; University of Toronto; Toronto ON Canada

Publisher

Wiley

Subject

Genetics (clinical),Hematology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/hae.12671/fullpdf

Reference7 articles.

1. Recombinant full-length factor VIII (FVIII) and extended half-life FVIII products in prophylaxis - new insight provided by pharmacokinetic modelling;Gringeri;Haemophilia,2015

2. Population pharmacokinetics of recombinant factor VIII: the relationships of pharmacokinetics to age and body weight;Björkman;Blood,2012

3. Population pharmacokinetic analysis of long-lasting recombinant factor VIII Fc fusion protein (rFVIIIFc) in patients with severe haemophilia A;Neelakantan;J Thromb Haemost,2013

4. Safety and prolonged activity of recombinant factor VIII Fc fusion protein in hemophilia A patients;Powell;Blood,2012

5. Phase 3 study of recombinant factor VIII Fc fusion protein in severe hemophilia A;Mahlangu;Blood,2014

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Perspective – The case for zero bleeds and drug bioequivalence in the treatment of congenital hemophilia A in 2021;Blood Reviews;2021-11

2. An update of the current pharmacotherapeutic armamentarium for hemophilia A;Expert Opinion on Pharmacotherapy;2021-08-18

3. Do nurses have the switch factor?;The Journal of Haemophilia Practice;2020-01-01

4. Pharmacokinetic and safety considerations when switching from standard to extended half-life clotting factor concentrates in hemophilia;Expert Review of Hematology;2019-07-29

5. Attempting to remedy sub-optimal medication adherence in haemophilia: The rationale for repeated ultrasound visualisations of the patient's joint status;Blood Reviews;2019-01